基本信息
views: 30
Career Trajectory
Bio
My Group is responsible for generating synthetic versions of our disease targets namely peptide-Human Leukocyte Antigen complexes (pHLA), for use in drug discovery and development. Our pipeline consists of a number of proprietary and partnered programmes ranging from very early stage target identification projects right through to our lead programme, tebentafusp (IMCgp100), which has been granted Fast Track Designation by the US Food & Drug Administration
Research Interests
Papers共 135 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
TRAUMA-ENGLANDno. 1 (2024): 49-55
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICAno. 2 (2024): 279-292
American journal of rhinology & allergyno. 2 (2023): 214-220
Karim W. Asi,Brian H. Cameron, Elliot R. Friedman,Jeffrey P. Radabaugh,Martin J. Citardi,Amber U. Luong,William C. Yao
Laryngoscope investigative otolaryngologyno. 3 (2023): 621-626
Poster Presentations - Proffered Abstracts (2020)
Pediatric Surgerypp.419-429, (2020)
Christopher J. Holland,Rory M. Crean,Johanne M. Pentier,Ben de Wet,Angharad Lloyd,Velupillai Srikannathasan,Nikolai Lissin,Katy A. Lloyd,Thomas H. Blicher,Paul J. Conroy,Miriam Hock,Robert J. Pengelly, Thomas E. Spinner,Brian Cameron, Elizabeth A. Potter, Anitha Jeyanthan,Peter E. Molloy,Malkit Sami,Milos Aleksic,Nathaniel Liddy,Ross A. Robinson,Stephen Harper,Marco Lepore,Chris R. Pudney,Marc W. van der Kamp,Pierre J. Rizkallah,Bent K. Jakobsen,Annelise Vuidepot,David K. Cole
Load More
Author Statistics
#Papers: 135
#Citation: 3186
H-Index: 27
G-Index: 54
Sociability: 7
Diversity: 3
Activity: 19
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn